New Approach to Prostate Cancer & Thyroid Dysfunction

Researchers at the Cleveland Clinic have identified a promising strategy for treating and preventing aggressive, drug-resistant prostate cancer. We\'ll talk with Nima Sharifi, M.D., of Cleveland Clinic\'s Lerner Research Institute, who led the effort.

Then, about 10% of us have some degree of thyroid dysfunction. But a new study by Mayo Clinic researchers suggests the most common drug treatment is significantly overused in people with mild hypothyroidism or no apparent thyroid dysfunction. On our Mayo Clinic Q&A segment, we\'ll talk with Dr. Juan Brito Campana, a Mayo Clinic endocrinologist, to learn what this may mean for patients.